Literature DB >> 7426335

Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.

J Askergren, M Björkholm, G Holm, B Johansson, H Mellstedt, R Sundblad, G Söderberg.   

Abstract

A randomized trial is reported which evaluates the effect of early diagnostic splenectomy on the prognosis of patients with Hodgkin's disease (HD) and uncertain prognosis. This was started in January 1973 and concluded in April 1979. Sixty-seven patients were entered in the study and 31 were randomized for splenectomy. All patients except 2 received total nodal irradiation, excluding the splenic and hepatic areas. After 40 months' observation there was no difference between the groups in respect of survival and the number of recurrences. However, relapses occurred earlier in the splenectomized patients. Pneumococcal septicaemia was recorded in 2 splenectomized patients. It is concluded that prognosis is not improved by diagnostic splenectomy in HD patients with uncertain prognosis and treated with total nodal irradiation.

Entities:  

Mesh:

Year:  1980        PMID: 7426335      PMCID: PMC2010376          DOI: 10.1038/bjc.1980.228

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  The role of surgery in the management of Hodgkin's disease.

Authors:  M Irving
Journal:  Br J Surg       Date:  1975-11       Impact factor: 6.939

2.  Solitary metastatic carcinoma of the spleen.

Authors:  J N McClure; Y H Park
Journal:  South Med J       Date:  1975-01       Impact factor: 0.954

3.  Laparotomy in Hodgkin's disease; incidence of complications, significance of splenic involvement.

Authors:  R Somers; J M Burgers; A A Hart; S J Van Coevorden
Journal:  Neth J Med       Date:  1976       Impact factor: 1.422

4.  Patterns of lymph node involvement in relation to hypotheses about the modes of spread of Hodgkin's disease.

Authors:  D W Smithers; S C Lillicrap; A Barnes
Journal:  Cancer       Date:  1974-11       Impact factor: 6.860

5.  Spleen involvement at the onset of Hodgkin's disease.

Authors:  A C Aisenberg; J M Goldman; J W Raker; C C Wang
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

6.  Splenectomy, chemotherapy, and survival in Hodgkin disease.

Authors:  F J Panettiere; C A Coltman; F C Delaney
Journal:  Arch Intern Med       Date:  1977-03

7.  Staging and treatment of Hodgkin's disease.

Authors:  J L Amiel; J P Droz
Journal:  Eur J Cancer       Date:  1978-01       Impact factor: 9.162

8.  Staging laparotomy and splenectomy for Hodgkin's disease.

Authors:  Y T Lee; R J Lukes; E J Finck; D I Feinstein; D R Powars
Journal:  Am Surg       Date:  1978-04       Impact factor: 0.688

9.  Septicemia and meningitis in children splenectomized for hodgkin's disease.

Authors:  R R Chilcote; R L Baehner; D Hammond
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

10.  Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.

Authors:  M Björkholm; G Holm; H Mellstedt; B Johansson; J Askergren; G Söderberg
Journal:  Scand J Haematol       Date:  1977-11
View more
  3 in total

1.  Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.

Authors:  M Björkholm; G Holm; J Askergren; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

2.  Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age.

Authors:  C Wedelin; M Björkholm; B Johansson; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.